Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2006 Apr 1;107(7):2786-9.
doi: 10.1182/blood-2004-01-0113. Epub 2005 Dec 15.

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants

Affiliations

CD40-activated B cells express full lymph node homing triad and induce T-cell chemotaxis: potential as cellular adjuvants

Michael von Bergwelt-Baildon et al. Blood. .

Abstract

CD40-activated B cells (CD40-B cells) have previously been introduced as an alternative source of antigen-presenting cells for immunotherapy. CD40-B cells can prime naive and expand memory T cells, and they can be generated in large numbers from very small amounts of peripheral blood derived from healthy individuals or cancer patients alike. Administration of CD40-B cells as a cellular adjuvant would require these cells to migrate toward secondary lymphoid organs and attract T cells in situ, processes guided by specific chemokines and chemokine receptors. Here, we demonstrate that primary, human CD40-B cells express a pattern of adhesion molecules and chemokine receptors necessary for homing to secondary lymphoid organs and have the capacity to migrate to cognate ligands. Furthermore, we show that CD40-B cells express important T-cell attractants and induce strong T-cell chemotaxis. These findings further support the use of CD40-B cells as cellular adjuvant for cancer immunotherapy.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Lymph-node homing phenotype of CD40-activated B cells. (A) Expression of lymph node homing receptors on CD40-B cells. First row: Expression by CD40-activated B cells after 14 days of culture; similar results were obtained at later time points. Second row: Expression by unstimulated B cells. Third row: Expression by immature monocyte-derived DCs. Fourth row: Expression by monocyte-derived DCs upon maturation with anti-CD40L/TNF-α. One representative experiment of at least 8 is shown. (B-C) Migration of CD40-B cells. Total number of CD40-B cells in bottom chamber of Costar transwell plate after 2-hour migration through a 5-μm filter. Migration was determined for different concentrations of chemoattractants: (B) Ligand of CXCR4: CXCL12. (C) Ligands of CCR7: CCL21 (□) and CCL19 (▪). Mean values are shown; at least 6 independent experiments were performed.
Figure 2.
Figure 2.
CD40-activated β cells induce T-cell migration. (A) Migration of T cells induced by supernatant from CD40-B cell cultures. CD4+ and CD8+ T cells were migrated for 2 hours through a 5-μm filter into the lower chamber of transwell plates containing supernatant from immature and mature monocyte-derived DCs and CD40-B cells as well as chemokines SDF-1α and SLC. Mean values of migration above background (cells spontaneously migrating to normal culture medium) in at least 7 independent experiments are shown. (B) Migration of T-cell subpopulations to supernatants from APC cultures. CD4+ were migrated for 2 hours through a 5-μm filter into the lower chamber of transwell plates containing SLC, SDF-1α, and supernatants from CD40-B, immature, and mature monocyte-derived DCs. T-cell subpopulations before and after migration are shown. From bottom to top: T naive (▪), T effector memory (formula image), T central memory (formula image), and T effector memory RA+ (□). Mean values of 3 independent experiments are shown.

References

    1. Renkvist N, Castelli C, Robbins PF, Parmiani G. A listing of human tumor antigens recognized by T cells. Cancer Immunol Immunother. 2001;50: 3-15. - PMC - PubMed
    1. Banchereau J, Steinman RM. Dendritic cells and the control of immunity. Nature. 1998;392: 245-252. - PubMed
    1. Rock KL, Benacerraf B, Abbas AK. Antigen presentation by hapten-specific B lymphocytes: I, role of surface immunoglobulin receptors. J Exp Med. 1984;160: 1102-1113. - PMC - PubMed
    1. Ranheim EA, Kipps TJ. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J Exp Med. 1993;177: 925-935. - PMC - PubMed
    1. Schultze JL, Michalak S, Seamon MJ, et al. CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy. J Clin Invest. 1997;100: 2757-2765. - PMC - PubMed

Publication types